Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
Novo Nordisk A/S (NVO): Is It The Most Oversold Healthcare Stock to Buy Now?
We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...
Omaha women deem popular weight loss drugs ‘life-changing’, high cost prevents more from using it
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
HealthLeaders Media1d
Insurers to Trump: stop Biden's Medicare and Medicaid obesity drug proposal
Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration that would require Medicare and Medicaid to cover anti-obesity drugs, ...
Axios on MSN1d
Insurers push back on Medicare and Medicaid coverage for GLP-1s
Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration ...
Ozempic, Wegovy coverage demand adds to employer health-insurance costs
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...